Loading...

Media is loading
 

Date of Award

Spring 2025

Degree Name

Master of Medical Science (Physician Assistant)

Department

Physician Assistant; College of Health Sciences

First Advisor

Kelly Moss

Abstract

Hyperemesis gravidarum (HG) affects approximately 0.3–3% of pregnancies globally, leading to severe nausea and vomiting that can result in significant physical, mental, and social consequences. It is one of the leading causes of hospitalization in early pregnancy, contributing to dehydration, electrolyte imbalances, and weight loss. Despite its prevalence, clinical practice guidelines emphasize individualized care while highlighting substantial gaps in high-quality research needed to address treatment limitations and improve outcomes. This poster explores the current landscape of hyperemesis gravidarum management, highlighting the limitations of existing therapies, the need for personalized care approaches, and the potential for future research to improve patient outcomes.

Share

COinS
 

Hyperemesis Gravidarum: Bridging Gaps In Care

Hyperemesis gravidarum (HG) affects approximately 0.3–3% of pregnancies globally, leading to severe nausea and vomiting that can result in significant physical, mental, and social consequences. It is one of the leading causes of hospitalization in early pregnancy, contributing to dehydration, electrolyte imbalances, and weight loss. Despite its prevalence, clinical practice guidelines emphasize individualized care while highlighting substantial gaps in high-quality research needed to address treatment limitations and improve outcomes. This poster explores the current landscape of hyperemesis gravidarum management, highlighting the limitations of existing therapies, the need for personalized care approaches, and the potential for future research to improve patient outcomes.